A phase I/II study of carboplatin plus gemcitabine for elderly patients with advanced non-small cell lung cancer: West Japan Thoracic Oncology Group Trial (WJTOG) 2905
- 6 February 2012
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 77 (1) , 110-115
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)Journal of Clinical Oncology, 2006
- Gemcitabine Plus Carboplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Patients With Stage IIIB or IV Non-Small-Cell Lung Cancer: A Phase III Randomized Study of the London Lung Cancer GroupJournal of Clinical Oncology, 2005
- A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patientsAnnals of Oncology, 2004
- Elderly Patients with Advanced Non-Small Cell Lung CancerOncology, 2003
- Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 2003
- Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized TrialJNCI: Journal of the National Cancer Institute, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 1999
- The national institute on aging and the national cancer institute seer collaborative study on comorbidity and early diagnosis of cancer in the elderlyCancer, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958